Læknablaðið : fylgirit - 01.05.1978, Qupperneq 105

Læknablaðið : fylgirit - 01.05.1978, Qupperneq 105
Ossi Laitinen, Marjatta Leirisalo and Anja Tiilikaninen Second Department of Medicine, Helsinki University Central Hospital, and Finnish Red Cross Blood Transfusion Service, Helsinki, Finland Introduction: One of the most important recent findings in rheumatoiogy has without doubt been the extra- ordinary association between the histocompa- tibility antigen HLA-B27 and certain rheumato- logical diseases such as ankylosing spondylitis, Reiter’s disease, spondylitis with inflammatory bowel disease, psoriatic spondylarthritis, and some forms of reactive arthritis, such as yersinia arthritis, salmonella arthritis and dysenteria arthritis (1, 2). In this contribution we shall present some aspects of yersinia arthritis and B27 leukocyte antigen and to some extent of the association of B27 and other reactive forms of arthritis. By choosing yersinia arthritis for a model for our study on B27 positive rheumatic disease it was possible to compare the B27 positive and negative patients on one hand, and female and male patients with "B27 positive rheumatic disease" on the other. This has not been possible in studies on ankylosing spondylitis because of the small number of B27 negative cases and the male predominance in spondyl- arthritis ancylopoetica. The purpose of our study was to obtain more detailed information on the influence of B27 on the clinicai picture of yersinia arthritis. R e s u 11 s : During the past 7 years we have investigated 48 patients with yersinia arthritis at Helsinki ON THE HLA-B27 POSITIVE RHEUMATIC DISEASE; ACUTE YERSINIA ARTHRITJS IN PATIENTS WITH ANKYLOSING SPONDYLITIS AND REITER"S DISEASE University Central Hospital (Table 1). Twenty six were female and 22 male. Thirty one of the patients were B27 positive and 17 were B27 nega- tive (Table 2). Out of the male yersinia arthri- tis patients 3/4 (77%) were B27 positive, whereas only about half (54%) of the females carried the antigen. Most of the patients were young, the mean age being 32 and 35 years in B27 negative and B27 positive groups, respectively. The mean yersinia enterocolitica agglutinin titre (highest values) was about 3 times higher in the B27 posi- tive group than in the B27 negative group (Table 3). Even if the difference between the values is not significant because of the great scatter of the individuals titres, the findings may be of interest because of the fact that the Ir genes, which are responsible for immunologic response in certain infections, have a definite correlation with B27. Table 4 shows some details of joint involvement in the B27 negative and positive yersinia arthritis patients. The frequency of affected joints was similar in both groups: knees, ankles, toes, fingers and wrists were affected most often, and there were no statistical differences between the groups regarding the number of affected joints or which joints were involved. By contrast, there was a significant difference in the duration of the joint symptoms: 18 out of 31 B27 positive patients had signs of acute synovitis longer than 3 months compared with only 2 out of 17 cases without B27 tissue antigen (X2=7.87; p<0.01; X2 test with Yates' correction). Table 1. Number, sex and age of patients with yersinia arthritis. No. of patients 48 Female/male ratio 26/22 Age Mean 33.3 Range 15-64 103
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132
Qupperneq 133
Qupperneq 134
Qupperneq 135
Qupperneq 136
Qupperneq 137
Qupperneq 138
Qupperneq 139
Qupperneq 140
Qupperneq 141
Qupperneq 142
Qupperneq 143
Qupperneq 144
Qupperneq 145
Qupperneq 146
Qupperneq 147
Qupperneq 148
Qupperneq 149
Qupperneq 150
Qupperneq 151
Qupperneq 152
Qupperneq 153
Qupperneq 154
Qupperneq 155
Qupperneq 156
Qupperneq 157
Qupperneq 158

x

Læknablaðið : fylgirit

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.